Comparing of the Pharmacokinetics, Immunogenicity and Safety of MV088 and Prolia® in Healthy Adults.
Clinical trial NCT04673799 · UNKNOWN
Trial details
- NCT number
- NCT04673799
- Sponsor
- Kunming Pharmaceuticals, Inc.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-22
- Primary completion
- 2021-10-18
- Enrollment
- 144
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.